Search research articles
Contact Us
Filters
Showing results (271-280 of 400) with videos related to
Page
of 40
Sort By:
Radiation Oncology (London, England)
|
January 16, 2014
Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors
Weilian Yang, Rolf F Barth, Tianyao Huo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1996
Characterization of two cloned human CB1 cannabinoid receptor isoforms
M Rinaldi-Carmona, B Calandra, D Shire, et al.
Journal of Neuro-Oncology
|
May 1, 1997
Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine
W Yang, R F Barth, J H Rotaru, et al.
Bioconjugate Chemistry
|
January 1, 1996
Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors
J Capala, R F Barth, M Bendayan, et al.
Genes & Development
|
June 1, 1989
Selection for B cells with productive IgL gene rearrangements occurs in the bursa of Fabricius during chicken embryonic development
W T McCormack, L W Tjoelker, C F Barth, et al.
Cell
|
March 10, 1989
Chicken IgL gene rearrangement involves deletion of a circular episome and addition of single nonrandom nucleotides to both coding segments
W T McCormack, L W Tjoelker, L M Carlson, et al.
Genes, Chromosomes & Cancer
|
July 4, 2001
Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract
T F Barth, M Bentz, F Leithäuser, et al.
Chemical Reviews
|
February 19, 2002
The Chemistry of Neutron Capture Therapy. (Chem. Rev. 1998, 98, 1515. Published on the Web May 20, 1998)
Albert H. Soloway, Werner Tjarks, Beverly A. Barnum, et al.
Cancer Gene Therapy
|
June 1, 1995
Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha
K Nishihara, R F Barth, N Wilkie, et al.
European Journal of Pharmacology
|
August 1, 2000
Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor
P Gouldson, B Calandra, P Legoux, et al.
Page
of 40
Search research articles
Search
Showing results (271-280 of 400) with videos related to
Sort By:
Page
of 40
Radiation Oncology (London, England)
|
January 16, 2014
Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors
Weilian Yang, Rolf F Barth, Tianyao Huo, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1996
Characterization of two cloned human CB1 cannabinoid receptor isoforms
M Rinaldi-Carmona, B Calandra, D Shire, et al.
Journal of Neuro-Oncology
|
May 1, 1997
Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine
W Yang, R F Barth, J H Rotaru, et al.
Bioconjugate Chemistry
|
January 1, 1996
Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors
J Capala, R F Barth, M Bendayan, et al.
Genes & Development
|
June 1, 1989
Selection for B cells with productive IgL gene rearrangements occurs in the bursa of Fabricius during chicken embryonic development
W T McCormack, L W Tjoelker, C F Barth, et al.
Cell
|
March 10, 1989
Chicken IgL gene rearrangement involves deletion of a circular episome and addition of single nonrandom nucleotides to both coding segments
W T McCormack, L W Tjoelker, L M Carlson, et al.
Genes, Chromosomes & Cancer
|
July 4, 2001
Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract
T F Barth, M Bentz, F Leithäuser, et al.
Chemical Reviews
|
February 19, 2002
The Chemistry of Neutron Capture Therapy. (Chem. Rev. 1998, 98, 1515. Published on the Web May 20, 1998)
Albert H. Soloway, Werner Tjarks, Beverly A. Barnum, et al.
Cancer Gene Therapy
|
June 1, 1995
Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha
K Nishihara, R F Barth, N Wilkie, et al.
European Journal of Pharmacology
|
August 1, 2000
Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor
P Gouldson, B Calandra, P Legoux, et al.
Page
of 40